Published 6 Jul 2026
In the CDMO market, success is about more than manufacturing capacity. It’s about having a partner who listens, responds, and is fully committed to your project.
As a mid-sized CDMO, Aspen API combines technical expertise with what our customers value most: full customer attention.
We are proud to be featured in Life Sciences Review Europe Magazine in June 2026, in which Marcella van Dinther shares the Aspen API vision on why personalized partnerships remains a key differentiator in today’s CDMO landscape.
Digital Edition (Page 42):
https://www.lifesciencesrevieweurope.com/digital/June2026/Research_Peptides_Manufacturing/page42
Online Feature:
https://www.lifesciencesrevieweurope.com/aspen-api-2026
